US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ADC Therapeutics SA

0.9966

+0.03653.80%

Post-market: 0.9900-0.0066-0.66%19:30 EDT

Volume:1.09M

Turnover:1.07M

Market Cap:126.61M

PE:-1.50

High:1.00

Open:0.9740

Low:0.9700

Close:0.9601

52wk High:4.98

52wk Low:0.7796

Shares:127.04M

Float Shares:88.56M

Volume Ratio:0.42

T/O Rate:1.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6636

EPS(LYR):-1.1224

ROE:-705.53%

ROA:-19.57%

PB:-0.55

PE(LYR):-0.89

Loading ...

Overview Company News Filings

BUZZ-ADC Therapeutics falls on higher rates of serious side-effects in cancer trial

ADC Therapeutics' Drug Regimen to Treat B-Cell Lymphoma Meets Primary Endpoint of Progression-Free Survival in Phase 3 Trial

MT Newswires Live

ADC Therapeutics Shares Plummet on Lymphoma Drug Trial Data, Possible Cost Cuts

ADC Therapeutics’ Zynlonta combination shows survival efficacy in DLBCL

ADC Therapeutics says LOTIS-5 trial shows Zynlonta plus Rituxan improves PFS in relapsed DLBCL

ADC Therapeutics - Plans Sbla Submission for Zynlonta Plus Rituximab in Q4 2026

THOMSON REUTERS

ADC Therapeutics - Zynlonta Plus Rituximab Achieves Statistical Significance on Primary Endpoint of Pfs in Lotis-5

THOMSON REUTERS

ADC Therapeutics Announces Results From Lotis-5 Phase 3 Confirmatory Clinical Trial of Zynlonta® in Combination With Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

THOMSON REUTERS

ADC Therapeutics shareholders approve annual meeting proposals

RBC Capital Reaffirms Their Buy Rating on ADC Therapeutics (ADCT)

ADC Therapeutics (ADCT) Receives a Buy from RBC Capital

Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)

ADC Therapeutics SA reports results for the quarter ended March 31 - Earnings Summary

Switzerland's ADC Therapeutics beats Q1 revenue estimates

ADC Therapeutics Q1 net loss narrows to $33 million; product revenue rises to $20 million

BRIEF-ADC Therapeutics Q1 Income From Operations USD -25.245 Million Vs. IBES Estimate USD -23.6 Million

ADC Therapeutics Sa - Lotis-5 Phase 3 Topline Data Expected Q2 2026; Full Lotis-5 and Lotis-7 Data by Year End

THOMSON REUTERS

ADC Therapeutics Q1 Basic EPS USD -0.21

THOMSON REUTERS

ADC Therapeutics Sa - Cash and Cash Equivalents $231.0 Mln as of March 31, 2026; Cash Runway Into 2028

THOMSON REUTERS

Press Release: ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ADCT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADCT\",,,,,undefined,":{"symbol":"ADCT","market":"US","secType":"STK","nameCN":"ADC Therapeutics SA","latestPrice":0.9966,"timestamp":1787342400000,"preClose":0.9601,"halted":0,"volume":1088237,"hourTrading":{"tag":"盘后","latestPrice":0.99,"preClose":0.9966,"latestTime":"19:30 EDT","volume":41259,"amount":41131.7992,"timestamp":1787355006194,"change":-0.0066,"changeRate":-0.006623,"amplitude":0.030102},"delay":0,"changeRate":0.03801687324237068,"floatShares":88562099,"shares":127044400,"eps":-0.6636,"marketStatus":"Market Closed","change":0.0365,"latestTime":"08-21 16:00:00 EDT","open":0.974,"high":1,"low":0.97,"amount":1074055.4218871,"amplitude":0.031247,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.6636,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1589515200000,"exchange":"NYSE","adjPreClose":0.9601,"preHourTrading":{"tag":"盘前","latestPrice":0.97,"preClose":0.9601,"latestTime":"08:36 EDT","volume":1977,"amount":1929.21464472,"timestamp":1787315818147,"change":0.0099,"changeRate":0.010311,"amplitude":0.028747},"postHourTrading":{"tag":"盘后","latestPrice":0.99,"preClose":0.9966,"latestTime":"19:30 EDT","volume":41259,"amount":41131.7992,"timestamp":1787355006194,"change":-0.0066,"changeRate":-0.006623,"amplitude":0.030102},"volumeRatio":0.4235120510143223,"impliedVol":0.2391,"impliedVolPercentile":0.2829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADCT\",,,,,undefined,":{"symbol":"ADCT","floatShares":88562099,"roa":"-19.57%","roe":"-705.53%","lyrEps":-1.122418,"volumeRatio":0.4235120510143223,"shares":127044400,"dividePrice":0,"high":1,"amplitude":0.031247,"preClose":0.9601,"low":0.97,"week52Low":0.7796,"pbRate":"-0.55","psRate":"1.59","week52High":4.98,"institutionHeld":0,"latestPrice":0.9966,"eps":-0.6636,"divideRate":0,"volume":1088237,"delay":0,"ttmEps":-0.6636,"open":0.974,"prevYearClose":3.53,"prevWeekClose":1.01,"prevMonthClose":1.05,"prevQuarterClose":1.07,"fiveDayClose":1.01,"twentyDayClose":1.15,"sixtyDayClose":3.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ADCT","fiscalQuarterEnding":"2026/06","expectedEps":-0.19,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2026-05-04","symbol":"ADCT","fiscalQuarterEnding":"2026/03","expectedEps":-0.19,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777867200000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2026-03-10","symbol":"ADCT","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2026-01-08","symbol":"ADCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1767848400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-10","symbol":"ADCT","fiscalQuarterEnding":"2025/09","expectedEps":-0.4,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADCT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.1667,"hold":0.3333,"sell":0,"strongSell":0.1667,"meanLabel":"BUY","meanPercent":0.1667,"analysts":6,"updateTime":1780977600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADCT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADCT","date":"2026-08-21","current":-1.501808,"percent":0.683401,"low":-12.066999,"twenty":-3.231101,"median":-1.825774,"eighty":-0.950329,"high":-0.211833,"avg":-2.483387,"sd":2.202753,"marketCap":122573753},"quantilePoints":[{"date":"2021-08-27","current":-11.293424,"twenty":-13.650793,"median":-10.46771,"eighty":-7.359556,"marketCap":2262671474},{"date":"2021-09-03","current":-10.70367,"twenty":-13.580872,"median":-10.540793,"eighty":-7.384851,"marketCap":2144512299},{"date":"2021-09-10","current":-10.251779,"twenty":-13.52111,"median":-10.481197,"eighty":-7.408985,"marketCap":2053974749},{"date":"2021-09-17","current":-11.052161,"twenty":-13.45836,"median":-10.46771,"eighty":-7.435734,"marketCap":2214333629},{"date":"2021-09-24","current":-10.833875,"twenty":-13.198396,"median":-10.540793,"eighty":-7.438849,"marketCap":2170599389},{"date":"2021-10-01","current":-10.110085,"twenty":-13.180467,"median":-10.524755,"eighty":-7.448202,"marketCap":2025585856},{"date":"2021-10-08","current":-9.026315,"twenty":-13.168515,"median":-10.454224,"eighty":-7.472335,"marketCap":1808449191},{"date":"2021-10-15","current":-9.753934,"twenty":-13.135646,"median":-10.436428,"eighty":-7.473115,"marketCap":1954229991},{"date":"2021-10-22","current":-10.002857,"twenty":-13.078277,"median":-10.42794,"eighty":-7.481386,"marketCap":2004102370},{"date":"2021-10-29","current":-11.101946,"twenty":-13.061078,"median":-10.428044,"eighty":-7.526636,"marketCap":2224308105},{"date":"2021-11-05","current":-8.978957,"twenty":-12.834049,"median":-10.42272,"eighty":-7.554108,"marketCap":2258872162},{"date":"2021-11-12","current":-8.072824,"twenty":-12.723974,"median":-10.414231,"eighty":-7.565853,"marketCap":2030912586},{"date":"2021-11-19","current":-6.968379,"twenty":-12.705361,"median":-10.401133,"eighty":-7.554108,"marketCap":1753062867},{"date":"2021-11-26","current":-6.773118,"twenty":-12.69819,"median":-10.353923,"eighty":-7.479732,"marketCap":1703940265},{"date":"2021-12-03","current":-6.547347,"twenty":-12.583617,"median":-10.339859,"eighty":-7.438226,"marketCap":1647142256},{"date":"2021-12-10","current":-6.211742,"twenty":-12.46461,"median":-10.324541,"eighty":-7.354126,"marketCap":1562712783},{"date":"2021-12-17","current":-6.071398,"twenty":-12.395125,"median":-10.267318,"eighty":-7.293144,"marketCap":1527405913},{"date":"2021-12-23","current":-6.486328,"twenty":-12.352471,"median":-10.253694,"eighty":-7.250074,"marketCap":1631791443},{"date":"2021-12-31","current":-6.162927,"twenty":-12.331832,"median":-10.171358,"eighty":-7.105523,"marketCap":1550432133},{"date":"2022-01-07","current":-6.040889,"twenty":-12.3175,"median":-10.121011,"eighty":-7.020244,"marketCap":1519730506},{"date":"2022-01-14","current":-5.253743,"twenty":-12.299574,"median":-10.110085,"eighty":-6.950448,"marketCap":1321705016},{"date":"2022-01-21","current":-4.780845,"twenty":-12.287114,"median":-10.104599,"eighty":-6.910115,"marketCap":1202736214},{"date":"2022-01-28","current":-4.561176,"twenty":-12.268538,"median":-10.039178,"eighty":-6.845427,"marketCap":1147473286},{"date":"2022-02-04","current":-4.921189,"twenty":-12.253403,"median":-9.999027,"eighty":-6.800821,"marketCap":1238043084},{"date":"2022-02-11","current":-4.664908,"twenty":-12.241668,"median":-9.853579,"eighty":-6.776298,"marketCap":1173569669},{"date":"2022-02-18","current":-4.63745,"twenty":-12.20396,"median":-9.827627,"eighty":-6.705493,"marketCap":1166661803},{"date":"2022-02-25","current":-5.165265,"twenty":-12.16083,"median":-9.796669,"eighty":-6.699929,"marketCap":1299446337},{"date":"2022-03-04","current":-4.698153,"twenty":-12.130264,"median":-9.752019,"eighty":-6.643297,"marketCap":1080697249},{"date":"2022-03-11","current":-4.678132,"twenty":-12.058414,"median":-9.720992,"eighty":-6.550137,"marketCap":1076092005},{"date":"2022-03-18","current":-4.758372,"twenty":-12.012124,"median":-9.665854,"eighty":-6.518116,"marketCap":1094549297},{"date":"2022-03-25","current":-4.444486,"twenty":-11.956638,"median":-9.585433,"eighty":-6.483887,"marketCap":1022347448},{"date":"2022-04-01","current":-4.952046,"twenty":-11.921655,"median":-9.540274,"eighty":-6.413783,"marketCap":1139099373},{"date":"2022-04-08","current":-4.621465,"twenty":-11.897133,"median":-9.469884,"eighty":-6.348106,"marketCap":1063057001},{"date":"2022-04-14","current":-4.738337,"twenty":-11.867453,"median":-9.451949,"eighty":-6.33378,"marketCap":1089940668},{"date":"2022-04-22","current":-4.22076,"twenty":-11.862719,"median":-9.396921,"eighty":-6.301447,"marketCap":970884429},{"date":"2022-04-29","current":-3.930248,"twenty":-11.833055,"median":-9.359488,"eighty":-6.223946,"marketCap":904059314},{"date":"2022-05-06","current":-3.656433,"twenty":-11.812416,"median":-9.256858,"eighty":-6.181232,"marketCap":841074723},{"date":"2022-05-13","current":-2.908534,"twenty":-11.778017,"median":-9.146539,"eighty":-6.147606,"marketCap":567629425},{"date":"2022-05-20","current":-2.774717,"twenty":-11.760818,"median":-9.106345,"eighty":-6.098857,"marketCap":541513862},{"date":"2022-05-27","current":-2.908534,"twenty":-11.750499,"median":-9.084629,"eighty":-6.040889,"marketCap":567629425},{"date":"2022-06-03","current":-2.833754,"twenty":-11.720228,"median":-9.022315,"eighty":-5.907257,"marketCap":553035434},{"date":"2022-06-10","current":-2.625158,"twenty":-11.687894,"median":-8.959641,"eighty":-5.295236,"marketCap":512325881},{"date":"2022-06-17","current":-2.499214,"twenty":-11.659183,"median":-8.930575,"eighty":-5.114619,"marketCap":487746528},{"date":"2022-06-24","current":-3.105322,"twenty":-11.651867,"median":-8.88457,"eighty":-5.035294,"marketCap":606034663},{"date":"2022-07-01","current":-3.361147,"twenty":-11.644552,"median":-8.853868,"eighty":-4.979156,"marketCap":655961473},{"date":"2022-07-08","current":-4.057778,"twenty":-11.623913,"median":-8.75365,"eighty":-4.940669,"marketCap":791916017},{"date":"2022-07-15","current":-3.187973,"twenty":-11.596394,"median":-8.716575,"eighty":-4.916514,"marketCap":622164863},{"date":"2022-07-22","current":-2.896726,"twenty":-11.592266,"median":-8.673367,"eighty":-4.863223,"marketCap":565325110},{"date":"2022-07-29","current":-2.916405,"twenty":-11.578533,"median":-8.603044,"eighty":-4.834506,"marketCap":569165634},{"date":"2022-08-05","current":-3.266689,"twenty":-11.556014,"median":-8.464639,"eighty":-4.783286,"marketCap":637526959},{"date":"2022-08-12","current":-4.23153,"twenty":-11.542643,"median":-8.395183,"eighty":-4.759708,"marketCap":791147913},{"date":"2022-08-19","current":-3.459173,"twenty":-11.525533,"median":-8.255681,"eighty":-4.732722,"marketCap":646744216},{"date":"2022-08-26","current":-2.929204,"twenty":-11.509575,"median":-8.173063,"eighty":-4.684434,"marketCap":547658701},{"date":"2022-09-02","current":-2.641625,"twenty":-11.483364,"median":-8.056523,"eighty":-4.669511,"marketCap":493891367},{"date":"2022-09-09","current":-2.6379,"twenty":-11.455979,"median":-8.007179,"eighty":-4.639426,"marketCap":493194896},{"date":"2022-09-16","current":-2.244566,"twenty":-11.377028,"median":-7.912344,"eighty":-4.562396,"marketCap":419655300},{"date":"2022-09-23","current":-2.090653,"twenty":-11.370438,"median":-7.851859,"eighty":-4.517953,"marketCap":390878937},{"date":"2022-09-30","current":-2.060725,"twenty":-11.366962,"median":-7.79397,"eighty":-4.436472,"marketCap":385283533},{"date":"2022-10-07","current":-2.035073,"twenty":-11.354091,"median":-7.644366,"eighty":-4.262834,"marketCap":380487472},{"date":"2022-10-14","current":-2.009421,"twenty":-11.339866,"median":-7.603949,"eighty":-4.11858,"marketCap":375691412},{"date":"2022-10-21","current":-2.043624,"twenty":-11.292651,"median":-7.573998,"eighty":-3.940266,"marketCap":382086159},{"date":"2022-10-28","current":-1.958117,"twenty":-11.279928,"median":-7.526636,"eighty":-3.826688,"marketCap":366099290},{"date":"2022-11-04","current":-1.808479,"twenty":-11.239552,"median":-7.477251,"eighty":-3.665858,"marketCap":338122270},{"date":"2022-11-11","current":-1.973997,"twenty":-11.231385,"median":-7.448202,"eighty":-3.589422,"marketCap":327730806},{"date":"2022-11-18","current":-1.887333,"twenty":-11.222682,"median":-7.42236,"eighty":-3.46397,"marketCap":313342624},{"date":"2022-11-25","current":-1.728451,"twenty":-11.200124,"median":-7.366779,"eighty":-3.315383,"marketCap":286964291},{"date":"2022-12-02","current":-1.742895,"twenty":-11.193244,"median":-7.345635,"eighty":-3.187973,"marketCap":289362321},{"date":"2022-12-09","current":-1.492534,"twenty":-11.176045,"median":-7.291334,"eighty":-3.134618,"marketCap":247796463},{"date":"2022-12-16","current":-1.564753,"twenty":-11.170878,"median":-7.255058,"eighty":-3.093515,"marketCap":259786614},{"date":"2022-12-23","current":-1.694748,"twenty":-11.160897,"median":-7.17358,"eighty":-3.058093,"marketCap":281368887},{"date":"2022-12-30","current":-1.848816,"twenty":-11.116799,"median":-7.102928,"eighty":-3.00812,"marketCap":306947877},{"date":"2023-01-06","current":-1.709192,"twenty":-11.103478,"median":-7.054747,"eighty":-2.977803,"marketCap":283766917},{"date":"2023-01-13","current":-2.407313,"twenty":-11.09068,"median":-7.013799,"eighty":-2.914951,"marketCap":399671715},{"date":"2023-01-20","current":-2.262874,"twenty":-11.070766,"median":-6.968379,"eighty":-2.901449,"marketCap":375691412},{"date":"2023-01-27","current":-2.431386,"twenty":-11.048053,"median":-6.93989,"eighty":-2.850284,"marketCap":403668432},{"date":"2023-02-03","current":-2.248921,"twenty":-11.041891,"median":-6.907359,"eighty":-2.831392,"marketCap":373374900},{"date":"2023-02-10","current":-2.137204,"twenty":-11.040337,"median":-6.853562,"eighty":-2.793261,"marketCap":354827118},{"date":"2023-02-17","current":-2.112917,"twenty":-11.037541,"median":-6.82206,"eighty":-2.774717,"marketCap":350794992},{"date":"2023-02-24","current":-1.942913,"twenty":-11.036477,"median":-6.802631,"eighty":-2.759761,"marketCap":322570108},{"date":"2023-03-03","current":-1.625273,"twenty":-11.030196,"median":-6.790993,"eighty":-2.711745,"marketCap":253217534},{"date":"2023-03-10","current":-1.420669,"twenty":-11.009222,"median":-6.773118,"eighty":-2.662154,"marketCap":221340216},{"date":"2023-03-17","current":-1.161423,"twenty":-11.000648,"median":-6.710401,"eighty":-2.626851,"marketCap":180949666},{"date":"2023-03-24","current":-0.995505,"twenty":-10.988916,"median":-6.70308,"eighty":-2.577952,"marketCap":155099713},{"date":"2023-03-31","current":-1.01106,"twenty":-10.962077,"median":-6.692438,"eighty":-2.500092,"marketCap":157523146},{"date":"2023-04-06","current":-1.062909,"twenty":-10.931816,"median":-6.657557,"eighty":-2.436957,"marketCap":165601257},{"date":"2023-04-14","current":-1.223642,"twenty":-10.921497,"median":-6.636713,"eighty":-2.398479,"marketCap":190643398},{"date":"2023-04-21","current":-1.156238,"twenty":-10.914296,"median":-6.554322,"eighty":-2.368796,"marketCap":180141855},{"date":"2023-04-28","current":-1.005875,"twenty":-10.904834,"median":-6.5307,"eighty":-2.325798,"marketCap":156715335},{"date":"2023-05-05","current":-1.005875,"twenty":-10.88536,"median":-6.511651,"eighty":-2.272503,"marketCap":156715335},{"date":"2023-05-12","current":-0.980447,"twenty":-10.869899,"median":-6.486328,"eighty":-2.248921,"marketCap":194682453},{"date":"2023-05-19","current":-1.053675,"twenty":-10.869899,"median":-6.450763,"eighty":-2.200348,"marketCap":209223051},{"date":"2023-05-26","current":-0.939765,"twenty":-10.862668,"median":-6.413105,"eighty":-2.159059,"marketCap":186604343},{"date":"2023-06-02","current":-0.968242,"twenty":-10.860198,"median":-6.392361,"eighty":-2.148819,"marketCap":192259020},{"date":"2023-06-09","current":-1.017061,"twenty":-10.859458,"median":-6.347111,"eighty":-2.134413,"marketCap":201952752},{"date":"2023-06-16","current":-0.939765,"twenty":-10.853773,"median":-6.33378,"eighty":-2.098346,"marketCap":186604343},{"date":"2023-06-23","current":-0.870604,"twenty":-10.841269,"median":-6.306322,"eighty":-2.090211,"marketCap":172871556},{"date":"2023-06-30","current":-0.878741,"twenty":-10.831773,"median":-6.301447,"eighty":-2.062435,"marketCap":174487178},{"date":"2023-07-07","current":-0.8584,"twenty":-10.828621,"median":-6.247355,"eighty":-2.059487,"marketCap":170448123},{"date":"2023-07-14","current":-0.630578,"twenty":-10.818557,"median":-6.223946,"eighty":-2.035073,"marketCap":125210706},{"date":"2023-07-21","current":-0.610237,"twenty":-10.814044,"median":-6.202589,"eighty":-2.002884,"marketCap":121171651},{"date":"2023-07-28","current":-0.504462,"twenty":-10.811422,"median":-6.177771,"eighty":-1.988044,"marketCap":100168565},{"date":"2023-08-04","current":-0.606168,"twenty":-10.808333,"median":-6.162927,"eighty":-1.965383,"marketCap":120363840},{"date":"2023-08-11","current":-0.717329,"twenty":-10.788727,"median":-6.115637,"eighty":-1.932105,"marketCap":130057572},{"date":"2023-08-18","current":-0.619309,"twenty":-10.777949,"median":-6.098857,"eighty":-1.908523,"marketCap":112285730},{"date":"2023-08-25","current":-0.614854,"twenty":-10.739473,"median":-6.068347,"eighty":-1.867341,"marketCap":111477919},{"date":"2023-09-01","current":-0.534656,"twenty":-10.727364,"median":-6.007328,"eighty":-1.832253,"marketCap":96937321},{"date":"2023-09-08","current":-0.485645,"twenty":-10.725115,"median":-5.944784,"eighty":-1.81759,"marketCap":88051400},{"date":"2023-09-15","current":-0.388962,"twenty":-10.721176,"median":-5.839526,"eighty":-1.773708,"marketCap":70521901},{"date":"2023-09-22","current":-0.324803,"twenty":-10.712425,"median":-5.305609,"eighty":-1.751033,"marketCap":58889422},{"date":"2023-09-29","current":-0.369803,"twenty":-10.702405,"median":-5.16679,"eighty":-1.729414,"marketCap":67048313},{"date":"2023-10-06","current":-0.38317,"twenty":-10.697346,"median":-5.107297,"eighty":-1.694748,"marketCap":69471746},{"date":"2023-10-13","current":-0.373145,"twenty":-10.694467,"median":-5.05238,"eighty":-1.67549,"marketCap":67654172},{"date":"2023-10-20","current":-0.345744,"twenty":-10.694104,"median":-5.001468,"eighty":-1.636973,"marketCap":62686134},{"date":"2023-10-27","current":-0.291788,"twenty":-10.681866,"median":-4.994411,"eighty":-1.626101,"marketCap":52903543},{"date":"2023-11-03","current":-0.311927,"twenty":-10.661649,"median":-4.952046,"eighty":-1.553198,"marketCap":56554848},{"date":"2023-11-10","current":-0.211833,"twenty":-10.658129,"median":-4.93535,"eighty":-1.49579,"marketCap":37813633},{"date":"2023-11-17","current":-0.287769,"twenty":-10.652738,"median":-4.919922,"eighty":-1.466535,"marketCap":51368702},{"date":"2023-11-24","current":-0.33352,"twenty":-10.64287,"median":-4.910192,"eighty":-1.446594,"marketCap":59535671},{"date":"2023-12-01","current":-0.375606,"twenty":-10.630908,"median":-4.885262,"eighty":-1.31697,"marketCap":67048313},{"date":"2023-12-08","current":-0.484215,"twenty":-10.549994,"median":-4.844915,"eighty":-1.223642,"marketCap":86435778},{"date":"2023-12-13","current":-0.466114,"twenty":-10.54793,"median":-4.838513,"eighty":-1.195643,"marketCap":83204534},{"date":"2023-12-20","current":-0.610926,"twenty":-10.546554,"median":-4.831835,"eighty":-1.192532,"marketCap":109054486},{"date":"2023-12-29","current":-0.719535,"twenty":-10.54425,"median":-4.805252,"eighty":-1.158312,"marketCap":128441950},{"date":"2024-01-05","current":-0.85077,"twenty":-10.540793,"median":-4.794574,"eighty":-1.119943,"marketCap":151868469},{"date":"2024-01-12","current":-0.936753,"twenty":-10.508716,"median":-4.768224,"eighty":-1.078085,"marketCap":167216879},{"date":"2024-01-19","current":-0.828144,"twenty":-10.486701,"median":-4.761711,"eighty":-1.062909,"marketCap":147829414},{"date":"2024-01-26","current":-1.172072,"twenty":-10.459619,"median":-4.750335,"eighty":-1.05774,"marketCap":209223051},{"date":"2024-02-02","current":-1.629135,"twenty":-10.445532,"median":-4.728978,"eighty":-1.061876,"marketCap":290811963},{"date":"2024-02-09","current":-1.778472,"twenty":-10.443278,"median":-4.692209,"eighty":-1.062909,"marketCap":317469726},{"date":"2024-02-16","current":-2.249111,"twenty":-10.432331,"median":-4.678231,"eighty":-1.062909,"marketCap":401482071},{"date":"2024-02-23","current":-2.212908,"twenty":-10.428728,"median":-4.671459,"eighty":-1.06602,"marketCap":395019583},{"date":"2024-03-01","current":-2.185756,"twenty":-10.428023,"median":-4.654836,"eighty":-1.071205,"marketCap":390172717},{"date":"2024-03-08","current":-2.249111,"twenty":-10.424808,"median":-4.63745,"eighty":-1.076163,"marketCap":401482071},{"date":"2024-03-15","current":-1.285802,"twenty":-10.422173,"median":-4.564227,"eighty":-1.078085,"marketCap":308660513},{"date":"2024-03-22","current":-1.584905,"twenty":-10.418227,"median":-4.534645,"eighty":-1.080526,"marketCap":380461220},{"date":"2024-03-28","current":-1.443948,"twenty":-10.414553,"median":-4.517949,"eighty":-1.084825,"marketCap":346624105},{"date":"2024-04-05","current":-1.619285,"twenty":-10.41109,"median":-4.460118,"eighty":-1.101278,"marketCap":388714175},{"date":"2024-04-12","current":-1.608971,"twenty":-10.405728,"median":-4.414434,"eighty":-1.124091,"marketCap":386238289},{"date":"2024-04-19","current":-1.636475,"twenty":-10.398069,"median":-4.295892,"eighty":-1.140683,"marketCap":392840653},{"date":"2024-04-26","current":-1.52646,"twenty":-10.377654,"median":-4.22076,"eighty":-1.158312,"marketCap":366431197},{"date":"2024-05-03","current":-1.631766,"twenty":-10.352893,"median":-4.075824,"eighty":-1.165683,"marketCap":391710220},{"date":"2024-05-10","current":-1.934067,"twenty":-10.348284,"median":-3.980337,"eighty":-1.180256,"marketCap":439584360},{"date":"2024-05-17","current":-1.730926,"twenty":-10.340625,"median":-3.906874,"eighty":-1.192532,"marketCap":393413574},{"date":"2024-05-24","current":-1.541071,"twenty":-10.334498,"median":-3.812485,"eighty":-1.194606,"marketCap":350262319},{"date":"2024-05-31","current":-1.452163,"twenty":-10.330668,"median":-3.709778,"eighty":-1.199791,"marketCap":330054878},{"date":"2024-06-07","current":-1.447929,"twenty":-10.31535,"median":-3.648185,"eighty":-1.208125,"marketCap":329092619},{"date":"2024-06-14","current":-1.397125,"twenty":-10.277142,"median":-3.605165,"eighty":-1.211348,"marketCap":317545509},{"date":"2024-06-21","current":-1.121934,"twenty":-10.271367,"median":-3.518578,"eighty":-1.193907,"marketCap":254998666},{"date":"2024-06-28","current":-1.337853,"twenty":-10.263268,"median":-3.471164,"eighty":-1.189673,"marketCap":304073881},{"date":"2024-07-05","current":-1.38019,"twenty":-10.257141,"median":-3.348535,"eighty":-1.19196,"marketCap":313696473},{"date":"2024-07-12","current":-1.617278,"twenty":-10.252545,"median":-3.309982,"eighty":-1.192532,"marketCap":367582983},{"date":"2024-07-19","current":-1.456397,"twenty":-10.216209,"median":-3.227331,"eighty":-1.193632,"marketCap":331017137},{"date":"2024-07-26","current":-1.536837,"twenty":-10.17855,"median":-3.168294,"eighty":-1.196955,"marketCap":349300060},{"date":"2024-08-02","current":-1.219309,"twenty":-10.152976,"median":-3.131778,"eighty":-1.206013,"marketCap":277130626},{"date":"2024-08-09","current":-1.196249,"twenty":-10.129098,"median":-3.105322,"eighty":-1.206013,"marketCap":257082217},{"date":"2024-08-16","current":-1.254712,"twenty":-10.119051,"median":-3.0699,"eighty":-1.206013,"marketCap":269646385},{"date":"2024-08-23","current":-1.380633,"twenty":-10.114056,"median":-3.058093,"eighty":-1.208237,"marketCap":296707671},{"date":"2024-08-30","current":-1.304181,"twenty":-10.110695,"median":-3.015052,"eighty":-1.213715,"marketCap":280277605},{"date":"2024-09-06","current":-1.214237,"twenty":-10.110085,"median":-2.991185,"eighty":-1.21474,"marketCap":260948115},{"date":"2024-09-13","current":-1.394403,"twenty":-10.106793,"median":-2.975442,"eighty":-1.217615,"marketCap":299666918},{"date":"2024-09-20","current":-1.497858,"twenty":-10.087017,"median":-2.922804,"eighty":-1.221909,"marketCap":321900270},{"date":"2024-09-27","current":-1.385707,"twenty":-10.06704,"median":-2.908534,"eighty":-1.226094,"marketCap":297798143},{"date":"2024-10-04","current":-1.480187,"twenty":-10.061536,"median":-2.908534,"eighty":-1.244382,"marketCap":318102562},{"date":"2024-10-11","current":-1.385707,"twenty":-10.034706,"median":-2.890823,"eighty":-1.252913,"marketCap":297798143},{"date":"2024-10-18","current":-1.403703,"twenty":-10.008442,"median":-2.857369,"eighty":-1.254735,"marketCap":301665652},{"date":"2024-10-25","current":-1.327219,"twenty":-10.000559,"median":-2.83769,"eighty":-1.260124,"marketCap":285228741},{"date":"2024-11-01","current":-1.327219,"twenty":-9.941584,"median":-2.829818,"eighty":-1.266404,"marketCap":285228741},{"date":"2024-11-08","current":-1.335379,"twenty":-9.884906,"median":-2.805994,"eighty":-1.26852,"marketCap":283300577},{"date":"2024-11-15","current":-1.089268,"twenty":-9.849765,"median":-2.785415,"eighty":-1.266404,"marketCap":231088184},{"date":"2024-11-22","current":-0.906964,"twenty":-9.834416,"median":-2.774717,"eighty":-1.247882,"marketCap":192412337},{"date":"2024-11-29","current":-1.102941,"twenty":-9.831664,"median":-2.768,"eighty":-1.232431,"marketCap":233988873},{"date":"2024-12-06","current":-1.426531,"twenty":-9.816532,"median":-2.755039,"eighty":-1.221042,"marketCap":302638501},{"date":"2024-12-13","current":-0.861388,"twenty":-9.798601,"median":-2.717649,"eighty":-1.214572,"marketCap":182743376},{"date":"2024-12-20","current":-0.893291,"twenty":-9.794893,"median":-2.684195,"eighty":-1.201737,"marketCap":189511649},{"date":"2024-12-27","current":-0.925194,"twenty":-9.784571,"median":-2.66058,"eighty":-1.192807,"marketCap":196279922},{"date":"2025-01-03","current":-0.920636,"twenty":-9.753934,"median":-2.6379,"eighty":-1.172072,"marketCap":195313026},{"date":"2025-01-10","current":-0.85683,"twenty":-9.750871,"median":-2.625158,"eighty":-1.155304,"marketCap":181776479},{"date":"2025-01-17","current":-0.834042,"twenty":-9.731723,"median":-2.579954,"eighty":-1.137157,"marketCap":176941999},{"date":"2025-01-24","current":-0.806696,"twenty":-9.723446,"median":-2.571574,"eighty":-1.113142,"marketCap":171140622},{"date":"2025-01-31","current":-0.765678,"twenty":-9.706291,"median":-2.503605,"eighty":-1.08113,"marketCap":162438556},{"date":"2025-02-07","current":-0.688199,"twenty":-9.680407,"median":-2.469905,"eighty":-1.071205,"marketCap":146001321},{"date":"2025-02-14","current":-0.729217,"twenty":-9.665088,"median":-2.431386,"eighty":-1.060843,"marketCap":154703387},{"date":"2025-02-21","current":-0.74289,"twenty":-9.635716,"median":-2.407313,"eighty":-1.055151,"marketCap":157604075},{"date":"2025-02-28","current":-0.802139,"twenty":-9.591926,"median":-2.391468,"eighty":-1.037402,"marketCap":170173725},{"date":"2025-03-07","current":-0.8386,"twenty":-9.580837,"median":-2.380068,"eighty":-1.030731,"marketCap":177908895},{"date":"2025-03-14","current":-0.843157,"twenty":-9.57088,"median":-2.344309,"eighty":-1.025765,"marketCap":178875791},{"date":"2025-03-21","current":-0.733775,"twenty":-9.545476,"median":-2.326042,"eighty":-1.016245,"marketCap":155670283},{"date":"2025-03-28","current":-0.93531,"twenty":-9.512951,"median":-2.279726,"eighty":-1.014294,"marketCap":147634918},{"date":"2025-04-04","current":-0.740715,"twenty":-9.494543,"median":-2.272503,"eighty":-1.01106,"marketCap":116918928},{"date":"2025-04-11","current":-0.765824,"twenty":-9.465756,"median":-2.26278,"eighty":-1.005875,"marketCap":120882282},{"date":"2025-04-17","current":-0.759547,"twenty":-9.458041,"median":-2.257456,"eighty":-0.990786,"marketCap":119891443},{"date":"2025-04-25","current":-0.83567,"twenty":-9.443422,"median":-2.249111,"eighty":-0.981385,"marketCap":131907120},{"date":"2025-05-02","current":-0.904785,"twenty":-9.406981,"median":-2.242428,"eighty":-0.971078,"marketCap":142816731},{"date":"2025-05-09","current":-0.79797,"twenty":-9.397357,"median":-2.212908,"eighty":-0.964582,"marketCap":125956423},{"date":"2025-05-16","current":-1.250964,"twenty":-9.362552,"median":-2.199332,"eighty":-0.960758,"marketCap":187446960},{"date":"2025-05-23","current":-1.476005,"twenty":-9.166378,"median":-2.17616,"eighty":-0.960758,"marketCap":221167577},{"date":"2025-05-30","current":-1.833424,"twenty":-9.091697,"median":-2.151776,"eighty":-0.960758,"marketCap":274723852},{"date":"2025-06-06","current":-2.276887,"twenty":-8.989941,"median":-2.150508,"eighty":-0.960758,"marketCap":341173303},{"date":"2025-06-13","current":-2.429121,"twenty":-8.891815,"median":-2.150508,"eighty":-0.960758,"marketCap":363984309},{"date":"2025-06-20","current":-2.005514,"twenty":-8.755565,"median":-2.142009,"eighty":-0.959185,"marketCap":300510206},{"date":"2025-06-27","current":-1.787092,"twenty":-8.675048,"median":-2.120138,"eighty":-0.959185,"marketCap":267781372},{"date":"2025-07-03","current":-1.886374,"twenty":-8.531227,"median":-2.098346,"eighty":-0.959185,"marketCap":282658115},{"date":"2025-07-11","current":-2.471211,"twenty":-8.261424,"median":-2.092951,"eighty":-0.959185,"marketCap":370291175},{"date":"2025-07-18","current":-2.328929,"twenty":-8.059192,"median":-2.092951,"eighty":-0.959185,"marketCap":348971380},{"date":"2025-07-25","current":-2.418791,"twenty":-7.908194,"median":-2.092951,"eighty":-0.959185,"marketCap":362436513},{"date":"2025-08-01","current":-2.074319,"twenty":-7.770295,"median":-2.090653,"eighty":-0.959185,"marketCap":310820168},{"date":"2025-08-08","current":-1.976969,"twenty":-7.602703,"median":-2.065916,"eighty":-0.959185,"marketCap":296232940},{"date":"2025-08-15","current":-2.111714,"twenty":-7.512018,"median":-2.057666,"eighty":-0.959185,"marketCap":358873070},{"date":"2025-08-22","current":-2.052136,"twenty":-7.444461,"median":-2.053991,"eighty":-0.959185,"marketCap":348748124},{"date":"2025-08-29","current":-2.151432,"twenty":-7.353512,"median":-2.048826,"eighty":-0.959185,"marketCap":365623033},{"date":"2025-09-05","current":-2.250729,"twenty":-7.284698,"median":-2.045516,"eighty":-0.957611,"marketCap":382497943},{"date":"2025-09-12","current":-2.204391,"twenty":-7.17722,"median":-2.045516,"eighty":-0.959185,"marketCap":374622985},{"date":"2025-09-19","current":-2.24411,"twenty":-7.027146,"median":-2.045516,"eighty":-0.959185,"marketCap":381372949},{"date":"2025-09-26","current":-2.283828,"twenty":-6.950448,"median":-2.045516,"eighty":-0.959185,"marketCap":388122912},{"date":"2025-10-03","current":-2.634677,"twenty":-6.859345,"median":-2.045516,"eighty":-0.959185,"marketCap":447747592},{"date":"2025-10-10","current":-3.038485,"twenty":-6.813222,"median":-2.045516,"eighty":-0.959185,"marketCap":516372223},{"date":"2025-10-17","current":-2.733974,"twenty":-6.777889,"median":-2.045516,"eighty":-0.959185,"marketCap":464622501},{"date":"2025-10-24","current":-2.694255,"twenty":-6.70308,"median":-2.045516,"eighty":-0.959185,"marketCap":457872537},{"date":"2025-10-31","current":-3.064964,"twenty":-6.659312,"median":-2.045516,"eighty":-0.959185,"marketCap":520872198},{"date":"2025-11-07","current":-2.753834,"twenty":-6.555716,"median":-2.045516,"eighty":-0.959185,"marketCap":467997483},{"date":"2025-11-14","current":-3.005267,"twenty":-6.512444,"median":-2.045516,"eighty":-0.959185,"marketCap":501702299},{"date":"2025-11-21","current":-2.960745,"twenty":-6.452875,"median":-2.045516,"eighty":-0.959185,"marketCap":494269672},{"date":"2025-11-28","current":-3.190777,"twenty":-6.399349,"median":-2.045516,"eighty":-0.959185,"marketCap":532671577},{"date":"2025-12-05","current":-2.626826,"twenty":-6.341528,"median":-2.045516,"eighty":-0.959185,"marketCap":438524972},{"date":"2025-12-12","current":-3.101732,"twenty":-6.279892,"median":-2.045516,"eighty":-0.959185,"marketCap":517806323},{"date":"2025-12-19","current":-2.893961,"twenty":-6.210522,"median":-2.045516,"eighty":-0.959185,"marketCap":483120732},{"date":"2025-12-26","current":-2.619406,"twenty":-6.174313,"median":-2.045516,"eighty":-0.959185,"marketCap":437286201},{"date":"2026-01-02","current":-2.619406,"twenty":-6.116552,"median":-2.045516,"eighty":-0.959185,"marketCap":437286201},{"date":"2026-01-09","current":-2.649087,"twenty":-6.068957,"median":-2.045516,"eighty":-0.959185,"marketCap":442241286},{"date":"2026-01-16","current":-2.634246,"twenty":-5.901765,"median":-2.045516,"eighty":-0.959185,"marketCap":439763744},{"date":"2026-01-23","current":-2.819757,"twenty":-5.284863,"median":-2.045516,"eighty":-0.959185,"marketCap":470733021},{"date":"2026-01-30","current":-2.790075,"twenty":-5.088991,"median":-2.045516,"eighty":-0.959185,"marketCap":465777937},{"date":"2026-02-06","current":-2.901381,"twenty":-4.995021,"median":-2.045516,"eighty":-0.959185,"marketCap":484359504},{"date":"2026-02-13","current":-2.983006,"twenty":-4.932566,"median":-2.045516,"eighty":-0.959185,"marketCap":497985986},{"date":"2026-02-20","current":-3.131414,"twenty":-4.911171,"median":-2.045516,"eighty":-0.959185,"marketCap":522761408},{"date":"2026-02-27","current":-3.06463,"twenty":-4.845525,"median":-2.045516,"eighty":-0.959185,"marketCap":511612468},{"date":"2026-03-06","current":-3.109153,"twenty":-4.796099,"median":-2.045516,"eighty":-0.959185,"marketCap":519045095},{"date":"2026-03-13","current":-3.874852,"twenty":-4.760375,"median":-2.045516,"eighty":-0.959185,"marketCap":552642948},{"date":"2026-03-20","current":-3.598713,"twenty":-4.722876,"median":-2.045516,"eighty":-0.959185,"marketCap":513259198},{"date":"2026-03-27","current":-3.527451,"twenty":-4.678191,"median":-2.045516,"eighty":-0.959185,"marketCap":503095649},{"date":"2026-04-02","current":-3.384928,"twenty":-4.65685,"median":-2.045516,"eighty":-0.959185,"marketCap":482768552},{"date":"2026-04-10","current":-3.349297,"twenty":-4.564837,"median":-2.045516,"eighty":-0.959185,"marketCap":477686778},{"date":"2026-04-17","current":-3.901575,"twenty":-4.509935,"median":-2.045516,"eighty":-0.959185,"marketCap":556454279},{"date":"2026-04-24","current":-3.531483,"twenty":-4.405084,"median":-2.045516,"eighty":-0.959185,"marketCap":503670705},{"date":"2026-05-01","current":-3.370961,"twenty":-4.237089,"median":-2.045516,"eighty":-0.959185,"marketCap":480776582},{"date":"2026-05-08","current":-3.481789,"twenty":-4.037487,"median":-2.045516,"eighty":-0.959185,"marketCap":476966842},{"date":"2026-05-15","current":-3.119683,"twenty":-3.901023,"median":-2.045516,"eighty":-0.959185,"marketCap":427362290},{"date":"2026-05-22","current":-3.156822,"twenty":-3.812493,"median":-2.045516,"eighty":-0.959185,"marketCap":432449937},{"date":"2026-05-29","current":-3.203246,"twenty":-3.708534,"median":-2.045516,"eighty":-0.957611,"marketCap":438809495},{"date":"2026-06-05","current":-1.22559,"twenty":-3.659213,"median":-2.045371,"eighty":-0.959185,"marketCap":167892328},{"date":"2026-06-12","current":-0.984186,"twenty":-3.606309,"median":-2.035745,"eighty":-0.9549,"marketCap":134822627},{"date":"2026-06-18","current":-1.03061,"twenty":-3.579149,"median":-2.014101,"eighty":-0.952838,"marketCap":141182185},{"date":"2026-06-26","current":-0.965616,"twenty":-3.517592,"median":-2.005514,"eighty":-0.952404,"marketCap":132278804},{"date":"2026-07-02","current":-1.058464,"twenty":-3.482883,"median":-1.993255,"eighty":-0.950657,"marketCap":144997920},{"date":"2026-07-10","current":-1.20702,"twenty":-3.415119,"median":-1.976913,"eighty":-0.950657,"marketCap":165348505},{"date":"2026-07-17","current":-1.253444,"twenty":-3.370191,"median":-1.946219,"eighty":-0.950657,"marketCap":171708063},{"date":"2026-07-24","current":-1.132742,"twenty":-3.347515,"median":-1.930665,"eighty":-0.950657,"marketCap":155173212},{"date":"2026-07-31","current":-1.03061,"twenty":-3.315383,"median":-1.903985,"eighty":-0.950329,"marketCap":141182185},{"date":"2026-08-07","current":-1.049179,"twenty":-3.2743,"median":-1.886374,"eighty":-0.950329,"marketCap":143726008},{"date":"2026-08-14","current":-1.383282,"twenty":-3.257561,"median":-1.843611,"eighty":-0.950329,"marketCap":134051079},{"date":"2026-08-21","current":-1.264847,"twenty":-3.231101,"median":-1.825774,"eighty":-0.950329,"marketCap":122573753}],"updateTime":1787459470384},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADCT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640598187","title":"BUZZ-ADC Therapeutics falls on higher rates of serious side-effects in cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640598187","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640598187?lang=en_us&edition=fundamental","pubTime":"2026-06-04 06:29","pubTimestamp":1780525789,"startTime":"0","endTime":"0","summary":"BUZZ-ADC Therapeutics falls on higher rates of serious side-effects in cancer trial** U.S.-listed shares of Switzerland-based drugmaker ADC Therapeutics ADCT.N fall 45.8% to $1.67 in extended trading** Company posts late-stage data testing Zynlonta, its approved blood cancer drug, with Roche's ROPC.S cancer antibody rituximab, in patients with relapsed or refractory diffuse large B-cell lymphoma, an aggressive blood cancer** Company says the combination met the main goal of delaying disease progression, with patients living 6.1 months without their disease worsening, versus 4.7 months for standard treatment** However, fatal adverse events were higher with the Zynlonta combination at 13.2% vs 4.6%, while serious side-effects and treatment withdrawals were also higher - ADC** Company plans to discuss the treatment's benefit-risk profile with the U.S. FDA and aims to file a supplemental approval application in Q4 2026** Shares down ~13% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nL4N42B20Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADCT","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640748184","title":"ADC Therapeutics' Drug Regimen to Treat B-Cell Lymphoma Meets Primary Endpoint of Progression-Free Survival in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640748184","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640748184?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:04","pubTimestamp":1780520662,"startTime":"0","endTime":"0","summary":"ADC Therapeutics  said late Wednesday its phase 3 trial of Zynlonta with rituximab to treat large B-cell lymphoma met the primary endpoint of progression-free survival, with a media PFS of 6.1 months.Overall response rate achieved was 58.1% while complete response rate stood at 39.5%. There was no detrimental effect to the overall survival secondary efficacy endpoint, according to a statement.Grade 3 or above treatment emergent adverse events were observed in more than 5% of patients across both arms, with grade 5 event mostly in patients aged 75 and above, the company said.The company said it plans to carry out a pre-biologics license application meeting in August and preparing for a planned sBLA submission in Q4.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","LENZ","BK4231","BK4539","ADCT","BK4139","ADC","BK4007","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640841431","title":"ADC Therapeutics Shares Plummet on Lymphoma Drug Trial Data, Possible Cost Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2640841431","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640841431?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:53","pubTimestamp":1780519980,"startTime":"0","endTime":"0","summary":"Shares of ADC Therapeutics plummeted after the company said it may pursue near-term cost cuts after reporting data from a Phase 3 trial of a lymphoma treatment.Shares fell 38% to $1.90 in after-hours trading Wednesday. The stock closed down 2.8% at $3.08, down 13% this year.The company said Zynlonta in combination with rituximab achieved statistical significance on the primary endpoint of progression-free survival, without any detrimental effect on a secondary endpoint of overall survival. The treatment also led to a higher complete response rate and duration.The test arm saw a similar rate of Grade 3 treatment emergent adverse events but a higher rate of Grade 5 TEAEs, serious adverse events, and side effects that led to study drug withdrawal.\"In the context of a positive study, based on the totality of the data, we plan to discuss the benefit-risk profile of this combination with the U.S. FDA as we prepare for the planned supplemental biologics license application filing,\" Chief Exec","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADCT","BK4231","BK4539","BK4080","LENZ","BK4505","ADC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640318119","title":"ADC Therapeutics’ Zynlonta combination shows survival efficacy in DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2640318119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640318119?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:20","pubTimestamp":1780518013,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (ADCT) announced topline data from its Phase 3 LOTIS-5 confirmatory trial evaluating Zynlonta – loncastuximab tesirine-lpyl – in c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-zynlonta-combination-shows-survival-efficacy-in-dlbcl-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-zynlonta-combination-shows-survival-efficacy-in-dlbcl-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4539","BK4231","BK4080","LENZ","BK4007","BK4139","ADCT","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640818151","title":"ADC Therapeutics says LOTIS-5 trial shows Zynlonta plus Rituxan improves PFS in relapsed DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2640818151","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640818151?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:06","pubTimestamp":1780517165,"startTime":"0","endTime":"0","summary":"ADC Therapeutics reported topline Phase 3 LOTIS-5 results for ZYNLONTA with rituximab in relapsed or refractory diffuse large B-cell lymphoma.Results were released now; a fuller discussion is slated for a conference call later today.The study met its primary goal, showing better disease control versus standard immunochemotherapy, with no worsening in overall survival.Complete responses lasted longer in the ZYNLONTA regimen, supporting a stronger durability profile in responders.Safety was broadly comparable, but severe events, treatment withdrawals, and deaths were higher in the ZYNLONTA arm, concentrated in older patients.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL1mQ9Nm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","ADCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640418130","title":"ADC Therapeutics - Plans Sbla Submission for Zynlonta Plus Rituximab in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640418130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640418130?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:05","pubTimestamp":1780517101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA9JNMGR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","ADCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640218137","title":"ADC Therapeutics - Zynlonta Plus Rituximab Achieves Statistical Significance on Primary Endpoint of Pfs in Lotis-5","url":"https://stock-news.laohu8.com/highlight/detail?id=2640218137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640218137?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:05","pubTimestamp":1780517101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA9JNMGR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","ADCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189068","title":"ADC Therapeutics Announces Results From Lotis-5 Phase 3 Confirmatory Clinical Trial of Zynlonta® in Combination With Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189068?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:05","pubTimestamp":1780517101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA9JNMGR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ADCT","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640923181","title":"ADC Therapeutics shareholders approve annual meeting proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2640923181","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640923181?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:02","pubTimestamp":1780430551,"startTime":"0","endTime":"0","summary":"ADC Therapeutics held its annual general meeting on June 1, 2026, with all items put to shareholders adopted.Shareholders adopted the 2025 management report, standalone financial statements, consolidated financial statements, and took note of the auditor’s report.Investors granted discharge from liability to board directors and the executive committee for 2025.They adopted the proposed treatment of results, carrying forward the 2025 net loss.Shareholders also backed the slate of directors for a one-year term.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADC Therapeutics SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Secur","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL9lhv84:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634289940","title":"RBC Capital Reaffirms Their Buy Rating on ADC Therapeutics (ADCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634289940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634289940?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:17","pubTimestamp":1778501844,"startTime":"0","endTime":"0","summary":"In a report released on May 8, Leonid Timashev from RBC Capital maintained a Buy rating on ADC Therapeutics, with a price target of $6.00. The comp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-adc-therapeutics-adct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-adc-therapeutics-adct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","ADCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633917184","title":"ADC Therapeutics (ADCT) Receives a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2633917184","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633917184?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:41","pubTimestamp":1777981300,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on ADC Therapeutics yesterday and set a price target of $6.00. The company’s shares clo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/adc-therapeutics-adct-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/adc-therapeutics-adct-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","BK4505","BK4080","LU1267930573.SGD","BK4207","LU0708994859.HKD","LU0310800379.SGD","ADC","BK4231","LU0029864427.USD","ADCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149912","title":"Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149912?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:21","pubTimestamp":1777980070,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB). A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adc-therapeutics-adct-evolus-eols-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adc-therapeutics-adct-evolus-eols-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","BK4137","LU0128526141.USD","BK4585","ADCT","BK4505","LABU","XLV","BK4139","NUVB","HCSG","LU0029874061.USD","BK4231","BK4080","ADC","BK4581","BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632956604","title":"ADC Therapeutics SA reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2632956604","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632956604?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:32","pubTimestamp":1777901540,"startTime":"0","endTime":"0","summary":"ADC Therapeutics SA reports results for the quarter ended March 31 - Earnings SummaryADC Therapeutics SA ADCT.N reported a quarterly adjusted loss of 13 cents per share for the quarter ended March 31,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H1BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930756","title":"Switzerland's ADC Therapeutics beats Q1 revenue estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930756","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930756?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:40","pubTimestamp":1777894822,"startTime":"0","endTime":"0","summary":"Switzerland's ADC Therapeutics beats Q1 revenue estimatesOverviewSwitzerland antibody drug conjugate developer's Q1 revenue rose 15%, beating analyst expectationsQ1 net loss narrowed due to lower oper","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL1N41H0CJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","ADCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930125","title":"ADC Therapeutics Q1 net loss narrows to $33 million; product revenue rises to $20 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930125","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930125?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:32","pubTimestamp":1777894323,"startTime":"0","endTime":"0","summary":"ADC Therapeutics posted a first-quarter net loss of USD 33 million, narrowing from USD 38.6 million a year earlier; net loss per share improved to USD 0.21 from USD 0.36.Net product revenue rose 15% to USD 20 million, while total revenue fell to USD 20.85 million from USD 23.03 million on lower license revenue and royalties.Operating loss narrowed to USD 25.25 million from USD 28.46 million as operating expenses fell to USD 46.1 million from USD 51.5 million, driven by lower R&D spending.Cash and cash equivalents ended March 31 at USD 231 million, down from USD 261.3 million at year-end, with expected cash runway at least into 2028.LOTIS-5 Phase 3 topline data are expected in 2Q 2026, with full LOTIS-5 and LOTIS-7 data anticipated by year-end; Ameet Mallik said the company sees multiple near-term catalysts and expects growth acceleration starting in 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL95DMP7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADCT","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930959","title":"BRIEF-ADC Therapeutics Q1 Income From Operations USD -25.245 Million Vs. IBES Estimate USD -23.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930959","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930959?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:30","pubTimestamp":1777894248,"startTime":"0","endTime":"0","summary":"BRIEF-ADC Therapeutics Q1 Income From Operations USD -25.245 Million Vs. IBES Estimate USD -23.6 Million\n\n\nMay 04 (Reuters) - ADC Therapeutics Q1 operating expenses USD -46.096 million.\n\nQ1 net income USD -32.968 million vs. IBES estimate USD -33.9 million\nQ1 basic EPS USD -0.21","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nPLX872CD8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930482","title":"ADC Therapeutics Sa - Lotis-5 Phase 3 Topline Data Expected Q2 2026; Full Lotis-5 and Lotis-7 Data by Year End","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930482?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:30","pubTimestamp":1777894203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nPLX872CD8:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ADCT","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632593094","title":"ADC Therapeutics Q1 Basic EPS USD -0.21","url":"https://stock-news.laohu8.com/highlight/detail?id=2632593094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632593094?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:30","pubTimestamp":1777894203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nPLX872CD8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADCT","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632304809","title":"ADC Therapeutics Sa - Cash and Cash Equivalents $231.0 Mln as of March 31, 2026; Cash Runway Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2632304809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632304809?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:30","pubTimestamp":1777894203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nPLX872CD8:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADCT","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632301369","title":"Press Release: ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2632301369","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632301369?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:30","pubTimestamp":1777894200,"startTime":"0","endTime":"0","summary":"LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7 anticipated by year end. First quarter 2026 net product revenue of $20.0 million. \"During the first quarter, we continued to build momentum across our ZYNLONTA program,\" said Ameet Mallik, Chief Executive Officer of ADC Therapeutics. \"Looking ahead, we have multiple near-term catalysts, including topline results from LOTIS-5 anticipated in the second quarter, full results expected from both LOTIS-5 and LOTIS-7 by year-end, as well as additional updates from the investigator-initiated studies in indolent lymphomas ahead. We believe that we are well-positioned to expand ZYNLONTA's role across B-cell malignancies, accelerating our expected growth trajectory starting in 2027.\". Investigator-Initiated trials  evaluating ZYNLONTA in additional B-cell malignancies progressing. The University of Miami Sylvester Comprehensive Cancer Center-led multi-center trials of ZYNLONTA in combination with ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4505","LENZ","BK4539","ADCT","ADC","BK4080","BK4231","BK4139","R","BK4007","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":92,"code":"91000000","status":"200"}]}}